MARK AUERBACH - 23 Dec 2021 Form 3 Insider Report for PARDES BIOSCIENCES, INC.

Role: Director
Signature: /s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 23 Dec 2021
Net transactions value: $0
Form type: 3
Filing time: 27 Dec 2021, 16:27:31 UTC
Next filing: 10 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PRDS	Common Stock						70,390	23 Dec 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney Effective immediately following the effective time of the merger pursuant to that certain Agreement and Plan of Merger dated as of June 29, 2021, as amended, by and among Pardes Biosciences Sub, Inc. (f/k/a Pardes Biosciences, Inc.), Issuer (f/k/a FS Development Corp. II), and certain other parties thereto, the reporting person became a director of the Issuer.